Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hitoshi Ishikawa

Showing results (241-250 of 404) with videos related to

Pageof 41
Sort By:
International Journal of Radiation Oncology, Biology, Physics|January 13, 2006
Radiation therapy for T2N0 laryngeal cancer: A retrospective analysis for the impact of concurrent chemotherapy on local controlTetsuo Akimoto, Tetsuo Nonaka, Yoshizumi Kitamoto, et al.
Japanese Journal of Clinical Oncology|March 4, 2014
Usefulness of J-CAPRA score for high-risk prostate cancer patients treated with carbon ion radiotherapy plus androgen deprivation therapyKoichiro Akakura, Hiroshi Tsuji, Hiroyoshi Suzuki, et al.
Anticancer Research|June 3, 2006
An eight-year survivor with multiple brain metastases of non-small cell lung cancer: an autopsy caseHidemasa Kawamura, Yuko Nakayama, Hitoshi Ishikawa, et al.
International Journal of Hygiene and Environmental Health|March 20, 2012
Effects of occupational environmental controls and work management on chromosomal damage in dental technicians in JapanShigeo Ishikawa, Hitoshi Ishikawa, Taku Shindo, et al.
Journal of Radiation Research|January 25, 2020
Impact of RhoA overexpression on clinical outcomes in cervical squamous cell carcinoma treated with concurrent chemoradiotherapyKeiichi Tanaka, Yoshitaka Matsumoto, Hitoshi Ishikawa, et al.
In Vivo (Athens, Greece)|July 2, 2020
Salvage Photon or Proton Radiotherapy for Oligo-recurrence in Regional Lymph Nodes After Surgery for Non-small Cell Lung CancerMasatoshi Nakamura, Kayoko Ohnishi, Hitoshi Ishikawa, et al.
Journal of Radiation Research|March 11, 2015
Comparison of adverse effects of proton and X-ray chemoradiotherapy for esophageal cancer using an adaptive dose-volume histogram analysisHirokazu Makishima, Hitoshi Ishikawa, Toshiyuki Terunuma, et al.
Journal of Radiation Research|August 4, 2012
Risk factors for rectal bleeding associated with I-125 brachytherapy for prostate cancerKosaku Harada, Hitoshi Ishikawa, Yoshitaka Saito, et al.
Orphanet Journal of Rare Diseases|August 20, 2022
Incidence of Leber hereditary optic neuropathy in 2019 in Japan: a second nationwide questionnaire surveyFumio Takano, Kaori Ueda, Daniel A Godefrooij, et al.
International Journal of Radiation Oncology, Biology, Physics|September 24, 2004
Expression of hypoxic-inducible factor 1alpha predicts metastasis-free survival after radiation therapy alone in stage IIIB cervical squamous cell carcinomaHitoshi Ishikawa, Hideyuki Sakurai, Masatoshi Hasegawa, et al.
Pageof 41

Showing results (241-250 of 404) with videos related to

Sort By:
Pageof 41
International Journal of Radiation Oncology, Biology, Physics|January 13, 2006
Radiation therapy for T2N0 laryngeal cancer: A retrospective analysis for the impact of concurrent chemotherapy on local controlTetsuo Akimoto, Tetsuo Nonaka, Yoshizumi Kitamoto, et al.
Japanese Journal of Clinical Oncology|March 4, 2014
Usefulness of J-CAPRA score for high-risk prostate cancer patients treated with carbon ion radiotherapy plus androgen deprivation therapyKoichiro Akakura, Hiroshi Tsuji, Hiroyoshi Suzuki, et al.
Anticancer Research|June 3, 2006
An eight-year survivor with multiple brain metastases of non-small cell lung cancer: an autopsy caseHidemasa Kawamura, Yuko Nakayama, Hitoshi Ishikawa, et al.
International Journal of Hygiene and Environmental Health|March 20, 2012
Effects of occupational environmental controls and work management on chromosomal damage in dental technicians in JapanShigeo Ishikawa, Hitoshi Ishikawa, Taku Shindo, et al.
Journal of Radiation Research|January 25, 2020
Impact of RhoA overexpression on clinical outcomes in cervical squamous cell carcinoma treated with concurrent chemoradiotherapyKeiichi Tanaka, Yoshitaka Matsumoto, Hitoshi Ishikawa, et al.
In Vivo (Athens, Greece)|July 2, 2020
Salvage Photon or Proton Radiotherapy for Oligo-recurrence in Regional Lymph Nodes After Surgery for Non-small Cell Lung CancerMasatoshi Nakamura, Kayoko Ohnishi, Hitoshi Ishikawa, et al.
Journal of Radiation Research|March 11, 2015
Comparison of adverse effects of proton and X-ray chemoradiotherapy for esophageal cancer using an adaptive dose-volume histogram analysisHirokazu Makishima, Hitoshi Ishikawa, Toshiyuki Terunuma, et al.
Journal of Radiation Research|August 4, 2012
Risk factors for rectal bleeding associated with I-125 brachytherapy for prostate cancerKosaku Harada, Hitoshi Ishikawa, Yoshitaka Saito, et al.
Orphanet Journal of Rare Diseases|August 20, 2022
Incidence of Leber hereditary optic neuropathy in 2019 in Japan: a second nationwide questionnaire surveyFumio Takano, Kaori Ueda, Daniel A Godefrooij, et al.
International Journal of Radiation Oncology, Biology, Physics|September 24, 2004
Expression of hypoxic-inducible factor 1alpha predicts metastasis-free survival after radiation therapy alone in stage IIIB cervical squamous cell carcinomaHitoshi Ishikawa, Hideyuki Sakurai, Masatoshi Hasegawa, et al.
Pageof 41